急性肠系膜缺血的死亡率与管理延迟:建立专病项目的必要性
单中心回顾性研究纳入2008年1月至2018年12月连续收治的67例急性肠系膜缺血患者,1个月生存率55.22%、1年生存率37.31%,院内死亡率50.74%。入院至诊断平均延迟4.83±5.03小时,入院至手术平均延迟10.64±8.80小时;多因素分析中早期治疗性抗凝为独立保护因素,入院时乳酸>3.31 mmol/l为独立预测因素。
要点
- 67例急性肠系膜缺血患者1个月生存率55.22%,1年生存率37.31%,院内死亡率50.74%。
- 入院至诊断平均延迟4.83±5.03小时,入院至手术平均延迟10.64±8.80小时。
- 多因素分析中早期治疗性抗凝为独立保护因素,入院时乳酸>3.31 mmol/l为独立预测因素。
核心结论
- 急性肠系膜缺血仍是严重且致命的疾病,因缺乏专病诊疗流程以实现早期诊断,手术管理延迟仍然过长。
研究设计与样本
- 单中心回顾性研究,纳入2008年1月至2018年12月连续收治的67例急性肠系膜缺血患者。
- 采用Kaplan-Meier分析评估短期与中期生存,收集诊断前及手术干预前的延迟时间。
- 采用单因素和多因素分析确定术后1个月死亡相关因素。
主要发现
- 67例患者1个月生存率55.22%,1年生存率37.31%,院内死亡率50.74%。
- 入院至诊断平均延迟4.83±5.03小时(95%CI 3.60-6.05),入院至手术治疗平均延迟10.64±8.80小时(95%CI 8.49-12.79)。
- 单因素分析中与术后1个月死亡率升高相关的变量:年龄>65岁(OR=3.52;P=0.046)、入院时(H0)乳酸>3.31 mmol/l(OR=7.38;P<0.001)、第1天(H24)乳酸>3.32 mmol/l(OR=5.60;P=0.002)、H0肌酐>95.9 μmol/l(OR=4.66;P=0.004)、H0天冬氨酸氨基转移酶(AST)>59 U/l(OR=3.55;P=0.017)、合并高血压(OR=9.32;P=0.040)。
- 多因素分析中早期治疗性抗凝为死亡的独立保护因素(z=-2.4;P=0.016),H0乳酸>3.31 mmol/l为术后1个月死亡的独立预测因素(z=2.62;P=0.009)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To study the mortality and delays of management of patients with acute mesenteric ischemia (AMI) admitted to the emergency department of a tertiary hospital and identify risk factors for 1-month mortality. METHODS: A single-center and retrospective study including all consecutive patients treated for AMI from January 2008 to December 2018 was conducted. Short- and medium-term survival was studied with a Kaplan-Meier analysis. Delays before diagnosis and surgical intervention were collected. To determine factors associated with mortality at 1 month postoperatively, univariate and multivariate analyzes were performed. RESULTS: The survival rate of the 67 included patients was 55.22% at 1 month and 37.31% at 1 year. In-hospital mortality was 50.74%. The average delay between admission and diagnosis was 4.83 ± 5.03 hr (95% confidence interval [CI], 3.60-6.05), and the delay between admission and surgical treatment was 10.64 ± 8.80 hr (95% CI, 8.49-12.79). The independent variables associated with an increased mortality at 1 month postoperatively in the univariate analysis were age >65 years old (odds ratio [OR] = 3.52; P = 0.046), lactate >3.31 mmol/l at admission (H0) (OR = 7.38; P < 0.001), lactate >3.32 mmol/l on day 1 (H24) (OR = 5.60; P = 0.002), creatinine >95.9 μmol/l at H0 (OR = 4.66; P = 0.004), aspartate aminotransferase (AST) >59 U/l at H0 (OR = 3.55; P = 0.017), and having hypertension as comorbidity (OR = 9.32; P = 0.040). Early curative anticoagulation (z = -2.4; P = 0.016) was an independent protective factor for mortality, and lactate >3.31 mmol/l at H0 (z = 2.62; P = 0.009) was an independent predictor factor of mortality at 1 month postoperatively in the multivariate analysis. CONCLUSION: AMI remains a serious and lethal condition with delays of surgical management remaining too long due to a lack of a dedicated therapeutic protocol allowing an early diagnosis.
引用
- Magnus L, Lejay A, Philouze G, et al. Mortality and Delays of Management of Acute Mesenteric Ischemia: The Need of a Dedicated Program. Ann Vasc Surg. 2022. PMID: 36549474. doi:10.1016/j.avsg.2022.12.070
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。